Schonfeld Strategic Advisors LLC Burning Rock Biotech LTD Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.16 - $3.47 $178,305 - $286,445	82,549 Added 71.46%	198,060 $556,000
Q4 2022 Feb 14, 2023	BUY	$1.73 - $2.95 $9,303 - $15,865	5,378 Added 4.88%	115,511 $259,000
Q3 2022 Nov 14, 2022	BUY	$2.39 - $3.96 $263,217 - $436,126	110,133 New	110,133 $264,000
Q2 2021 Aug 16, 2021	SELL	$26.14 - $37.45 $329,364 - $471,870	-12,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$23.5 - $39.58 $291,400 - $490,792	-12,400 Reduced 49.6%	12,600 $339,000
Q4 2020 Feb 16, 2021	BUY	$22.55 - $30.87 $563,750 - $771,750	25,000 New	25,000 $578,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $721M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.